Back to Search
Start Over
Changes in Body Mass Index with Longer-term Integrase Inhibitor Use: A Longitudinal Analysis of Data from the Randomized Trial to Prevent Vascular Events in Human Immunodeficiency Virus (REPRIEVE).
- Source :
- Clinical Infectious Diseases; Jun2023, Vol. 76 Issue 11, p2010-2013, 4p
- Publication Year :
- 2023
-
Abstract
- Over 2-years of follow-up, integrase strand transfer inhibitor (INSTI)-use was associated with weight gain among those on an INSTI <2 years at entry (+0.27 kg/m<superscript>2</superscript>/year; 95% confidence interval [CI],.22 to.33 vs +0.17 kg/m<superscript>2</superscript>/year; 95% CI,.12 to.23; P =.01), but not those on an entry INSTI >2 years. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 10584838
- Volume :
- 76
- Issue :
- 11
- Database :
- Complementary Index
- Journal :
- Clinical Infectious Diseases
- Publication Type :
- Academic Journal
- Accession number :
- 164219253
- Full Text :
- https://doi.org/10.1093/cid/ciad107